340 related articles for article (PubMed ID: 22306332)
21. Performance and characteristics evaluation of a sodium hyaluronate-based microneedle patch for a transcutaneous drug delivery system.
Hiraishi Y; Nakagawa T; Quan YS; Kamiyama F; Hirobe S; Okada N; Nakagawa S
Int J Pharm; 2013 Jan; 441(1-2):570-9. PubMed ID: 23137695
[TBL] [Abstract][Full Text] [Related]
22. Frontiers of transcutaneous vaccination systems: novel technologies and devices for vaccine delivery.
Matsuo K; Hirobe S; Okada N; Nakagawa S
Vaccine; 2013 May; 31(19):2403-15. PubMed ID: 23523401
[TBL] [Abstract][Full Text] [Related]
23. Compositional optimization and safety assessment of a hydrogel patch as a transcutaneous immunization device.
Matsuo K; Ishii Y; Quan YS; Kamiyama F; Asada H; Mukai Y; Okada N; Nakagawa S
Biol Pharm Bull; 2011; 34(12):1835-40. PubMed ID: 22130239
[TBL] [Abstract][Full Text] [Related]
24. Characteristics of immune induction by transcutaneous vaccination using dissolving microneedle patches in mice.
Hirobe S; Susai R; Takeuchi H; Eguchi R; Ito S; Quan YS; Kamiyama F; Okada N
Int J Pharm; 2021 May; 601():120563. PubMed ID: 33811967
[TBL] [Abstract][Full Text] [Related]
25. Permeation of antigen protein-conjugated nanoparticles and live bacteria through microneedle-treated mouse skin.
Kumar A; Li X; Sandoval MA; Rodriguez BL; Sloat BR; Cui Z
Int J Nanomedicine; 2011; 6():1253-64. PubMed ID: 21753877
[TBL] [Abstract][Full Text] [Related]
26. Enhanced immunization via dissolving microneedle array-based delivery system incorporating subunit vaccine and saponin adjuvant.
Zhao JH; Zhang QB; Liu B; Piao XH; Yan YL; Hu XG; Zhou K; Zhang YT; Feng NP
Int J Nanomedicine; 2017; 12():4763-4772. PubMed ID: 28740383
[TBL] [Abstract][Full Text] [Related]
27. Laser-engineered dissolving microneedle arrays for protein delivery: potential for enhanced intradermal vaccination.
McCrudden MT; Torrisi BM; Al-Zahrani S; McCrudden CM; Zaric M; Scott CJ; Kissenpfennig A; McCarthy HO; Donnelly RF
J Pharm Pharmacol; 2015 Mar; 67(3):409-25. PubMed ID: 24673568
[TBL] [Abstract][Full Text] [Related]
28. Novel Hydrogel-Forming Microneedle Array for Intradermal Vaccination in Mice Using Ovalbumin as a Model Protein Antigen.
Courtenay AJ; Rodgers AM; McCrudden MTC; McCarthy HO; Donnelly RF
Mol Pharm; 2019 Jan; 16(1):118-127. PubMed ID: 30452868
[TBL] [Abstract][Full Text] [Related]
29. Development of PLGA nanoparticle loaded dissolving microneedles and comparison with hollow microneedles in intradermal vaccine delivery.
Mönkäre J; Pontier M; van Kampen EEM; Du G; Leone M; Romeijn S; Nejadnik MR; O'Mahony C; Slütter B; Jiskoot W; Bouwstra JA
Eur J Pharm Biopharm; 2018 Aug; 129():111-121. PubMed ID: 29803720
[TBL] [Abstract][Full Text] [Related]
30. A fast-dissolving microneedle array loaded with chitosan nanoparticles to evoke systemic immune responses in mice.
Li Z; He Y; Deng L; Zhang ZR; Lin Y
J Mater Chem B; 2020 Jan; 8(2):216-225. PubMed ID: 31803892
[TBL] [Abstract][Full Text] [Related]
31. Analysis of immune response induction mechanisms implicating the dose-sparing effect of transcutaneous immunization using a self-dissolving microneedle patch.
Ito S; Hirobe S; Yamashita R; Sugiyama A; Takeuchi H; Eguchi R; Yoshida J; Oyamada T; Tachibana M; Okada N
Vaccine; 2022 Feb; 40(6):862-872. PubMed ID: 34998604
[TBL] [Abstract][Full Text] [Related]
32. Influence of microneedle shape on the transport of a fluorescent dye into human skin in vivo.
Bal SM; Kruithof AC; Zwier R; Dietz E; Bouwstra JA; Lademann J; Meinke MC
J Control Release; 2010 Oct; 147(2):218-24. PubMed ID: 20650292
[TBL] [Abstract][Full Text] [Related]
33. The development and characteristics of novel microneedle arrays fabricated from hyaluronic acid, and their application in the transdermal delivery of insulin.
Liu S; Jin MN; Quan YS; Kamiyama F; Katsumi H; Sakane T; Yamamoto A
J Control Release; 2012 Aug; 161(3):933-41. PubMed ID: 22634072
[TBL] [Abstract][Full Text] [Related]
34. IgG-loaded hyaluronan-based dissolving microneedles for intradermal protein delivery.
Mönkäre J; Reza Nejadnik M; Baccouche K; Romeijn S; Jiskoot W; Bouwstra JA
J Control Release; 2015 Nov; 218():53-62. PubMed ID: 26437262
[TBL] [Abstract][Full Text] [Related]
35. Permeation of sumatriptan succinate across human skin using multiple types of self-dissolving microneedle arrays fabricated from sodium hyaluronate.
Wu D; Katsumi H; Quan YS; Kamiyama F; Kusamori K; Sakane T; Yamamoto A
J Drug Target; 2016 Sep; 24(8):752-8. PubMed ID: 26878569
[TBL] [Abstract][Full Text] [Related]
36. Dissolving Microneedle Arrays with Optimized Needle Geometry for Transcutaneous Immunization.
Li Y; Hu X; Dong Z; Chen Y; Zhao W; Wang Y; Zhang L; Chen M; Wu C; Wang Q
Eur J Pharm Sci; 2020 Aug; 151():105361. PubMed ID: 32422374
[TBL] [Abstract][Full Text] [Related]
37. Evaluation needle length and density of microneedle arrays in the pretreatment of skin for transdermal drug delivery.
Yan G; Warner KS; Zhang J; Sharma S; Gale BK
Int J Pharm; 2010 May; 391(1-2):7-12. PubMed ID: 20188808
[TBL] [Abstract][Full Text] [Related]
38. Advances in transcutaneous vaccine delivery: do all ways lead to Rome?
Bal SM; Ding Z; van Riet E; Jiskoot W; Bouwstra JA
J Control Release; 2010 Dec; 148(3):266-82. PubMed ID: 20869998
[TBL] [Abstract][Full Text] [Related]
39. Transcutaneous immunization using microneedles and cubosomes: Mechanistic investigations using Optical Coherence Tomography and Two-Photon Microscopy.
Rattanapak T; Birchall J; Young K; Ishii M; Meglinski I; Rades T; Hook S
J Control Release; 2013 Dec; 172(3):894-903. PubMed ID: 23978683
[TBL] [Abstract][Full Text] [Related]
40. Dissolving Microneedle Arrays for Transdermal Delivery of Amphiphilic Vaccines.
An M; Liu H
Small; 2017 Jul; 13(26):. PubMed ID: 28544329
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
